A Risk Sciences International Case Study

External Peer Consultation of the Inorganic – Late Biomonitoring Approach Draft Screening Assessment Report

Inorganic substances

Client: Health Canada

Listing of the client in no way affirms the client's support, sponsorship, or validation in any form of Risk Sciences International or the RSI staff member(s) who conducted this project during their stay with RSI or prior to joining the company. This case study is displayed for informative purposes only to demonstrate the capacity of RSI staff members. This case study reveals no proprietary information or information deemed sensitive.

Project description:

External Peer Consultation of the Inorganic - Late Biomonitoring Approach Draft Screening Assessment Report

To support the Chemicals Management Plan under the Canadian Environmental Protection Act (CEPA), Health Canada sought expert peer consultation for a draft screening assessment report (DSAR) evaluating 47 inorganic substances identified as priorities. The client required independent scientific and technical expertise to assess whether the report’s conclusions—particularly regarding health effects, exposure pathways, and risk characterizations—were sound, complete, and defensible.

The work involved managing a structured external peer review process. This included identifying and screening potential reviewers for expertise and conflicts of interest, selecting suitable experts, and coordinating the delivery of charge questions and relevant materials. The consultation focused on critical scientific elements such as the appropriateness of biomarkers (e.g., whole blood concentrations), the use and description of biomonitoring equivalents (BEs), and the robustness of the weight-of-evidence approach used in the DSAR.

A primary deliverable consisted of a comprehensive report integrating detailed technical commentary and overarching observations from reviewers, systematically addressing charge questions pertaining to toxicological data, exposure estimations, and consistency with international assessment approaches. All comments and recommendations were submitted within the defined 15-business-day timeframe following receipt of the background materials, supporting the client’s objective of ensuring scientific rigour and transparency prior to publication.

Start: 2019

End: 2019

Experts related to this case study

Franco Momoli

Vice-President Chemical and Product Safety

Dr. Franco Momoli joined Risk Sciences International (RSI) in 2019 and currently serves as Vice-President, Chemical and Product Safety. In this role, he leads a multidisciplinary team of epidemiologists, risk assessors, toxicologists, and biostatisticians in conducting human health risk assessments...
Read More about Franco Momoli

Michael G. Tyshenko

Senior Health Risk Analyst

Dr. Michael G. Tyshenko is a Senior Health Risk Analyst at Risk Sciences International (RSI), where he has contributed since 2018 to some of the organization’s most complex and cross-cutting public health risk projects. As RSI’s lead on chemical peer...
Read More about Michael G. Tyshenko

More RSI Case Studies

RSI presents a very small selection of case studies to highlight some of its key work.

Risk Assessment of the Impact of Lethality Standards on Salmonellosis from Ready-to-Eat (RTE) Meat and Poultry Products

To support regulatory decision-making, a comprehensive risk assessment was conducted to evaluate how varying lethality performance standards would impact the public health burden of salmonellosis associated with Ready-to-Eat (RTE) meat and poultry products. The primary objective was to quantify the...
Read More about Risk Assessment of the Impact of Lethality Standards on Salmonellosis from Ready-to-Eat (RTE) Meat and Poultry Products

Risk-Based Decision-Making (RBDM) Support for Plasma Supply / Sufficiency

Facing renewed challenges in securing a reliable domestic plasma supply, Canadian Blood Services sought support to apply a Risk-Based Decision-Making (RBDM) framework. The objective was to assess the value and implications of expanding domestic plasma collection and processing capacity in...
Read More about Risk-Based Decision-Making (RBDM) Support for Plasma Supply / Sufficiency

Risk-Based Decision Making (RBDM) Compliance and Enforcement

Innovation, Science and Economic Development Canada (ISED), through its Spectrum Management Innovation Directorate, sought support in applying risk-based decision making (RBDM) across its compliance and enforcement responsibilities. The department was looking for a structured and data-driven approach to prioritize regulatory...
Read More about Risk-Based Decision Making (RBDM) Compliance and Enforcement

Evaluation of Drug Recall Communication and Risk Determination Processes

In response to public and ministerial concerns about the timeliness and adequacy of information shared during a major prescription drug recall, Health Canada commissioned an independent review to assess its response to the event. The situation involved a recall of...
Read More about Evaluation of Drug Recall Communication and Risk Determination Processes

Risk-based decision making framework

The Alliance of Blood Operators (ABO) sought to move its members toward a consistent, transparent approach to risk-based decision-making. Having worked through the development of a framework, the organization now wanted formal adoption, external validation, and practical application to real-world...
Read More about Risk-based decision making framework

Risk Model Framework for Foodborne Campylobacteriosis via Poultry Meat Pathway

To support national public health goals, RSI was tasked with developing a quantitative microbiological risk assessment (QMRA) model to estimate the human health risks associated with the consumption of chicken in New Zealand. The core objective was to quantify the...
Read More about Risk Model Framework for Foodborne Campylobacteriosis via Poultry Meat Pathway